<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD004292.pub2" GROUP_ID="RENAL" ID="334101112314303919" MERGED_FROM="" MODIFIED="2012-04-24 02:42:09 +0200" MODIFIED_BY="Narelle Willis" REVIEW_NO="059" REVMAN_SUB_VERSION="5.1.6" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="7.0">
<COVER_SHEET MODIFIED="2012-04-24 02:42:09 +0200" MODIFIED_BY="Narelle Willis">
<TITLE MODIFIED="2012-03-08 10:55:15 +1100" MODIFIED_BY="Narelle S Willis">Water for preventing urinary stones</TITLE>
<CONTACT MODIFIED="2012-04-24 02:42:09 +0200" MODIFIED_BY="Narelle Willis"><PERSON ID="E3818A6182E26AA201E74FE94A3F6050" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Qiang</FIRST_NAME><LAST_NAME>Wei</LAST_NAME><POSITION>Associate Professor</POSITION><EMAIL_1>wq933@hotmail.com</EMAIL_1><ADDRESS><DEPARTMENT>Department of Urology</DEPARTMENT><ORGANISATION>West China Hospital, Sichuan University</ORGANISATION><ADDRESS_1>No. 37, Guo Xue Xiang</ADDRESS_1><CITY>Chengdu</CITY><ZIP>610041</ZIP><REGION>Sichuan</REGION><COUNTRY CODE="CN">China</COUNTRY><PHONE_1>+86 28 8542 2079</PHONE_1><PHONE_2>+86 28 8542 2078</PHONE_2><FAX_1>+86 28 8542 2079</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2012-04-24 02:42:09 +0200" MODIFIED_BY="Narelle Willis"><PERSON ID="42376767012988964103110602023444" ROLE="AUTHOR"><PREFIX>Mr</PREFIX><FIRST_NAME>Yige</FIRST_NAME><LAST_NAME>Bao</LAST_NAME><EMAIL_1>yige.bao@gmail.com</EMAIL_1><EMAIL_2>Baoyige@hotmail.com</EMAIL_2><ADDRESS><DEPARTMENT>Department of Urology</DEPARTMENT><ORGANISATION>West China Hospital, Sichuan University</ORGANISATION><ADDRESS_1>No. 37, Guo Xue Xiang</ADDRESS_1><CITY>Chengdu</CITY><ZIP>610041</ZIP><REGION>Sichuan</REGION><COUNTRY CODE="CN">China</COUNTRY><PHONE_1>+86 13882251657</PHONE_1><FAX_1>+862885502723</FAX_1></ADDRESS></PERSON><PERSON ID="E3818A6182E26AA201E74FE94A3F6050" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Qiang</FIRST_NAME><LAST_NAME>Wei</LAST_NAME><POSITION>Associate Professor</POSITION><EMAIL_1>wq933@hotmail.com</EMAIL_1><ADDRESS><DEPARTMENT>Department of Urology</DEPARTMENT><ORGANISATION>West China Hospital, Sichuan University</ORGANISATION><ADDRESS_1>No. 37, Guo Xue Xiang</ADDRESS_1><CITY>Chengdu</CITY><ZIP>610041</ZIP><REGION>Sichuan</REGION><COUNTRY CODE="CN">China</COUNTRY><PHONE_1>+86 28 8542 2079</PHONE_1><PHONE_2>+86 28 8542 2078</PHONE_2><FAX_1>+86 28 8542 2079</FAX_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2012-04-18 13:51:11 +1000" MODIFIED_BY="Gail Y Higgins">
<UP_TO_DATE>
<DATE DAY="18" MONTH="4" YEAR="2012"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="18" MONTH="4" YEAR="2012"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="15" MONTH="10" YEAR="2014"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="3" YEAR="2003"/>
<REVIEW_PUBLISHED ISSUE="3" YEAR="2004"/>
<LAST_CITATION_ISSUE ISSUE="3" YEAR="2004"/>
</DATES>
<WHATS_NEW MODIFIED="2012-04-18 16:21:11 +1000" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2012-04-18 16:21:11 +1000" MODIFIED_BY="Narelle S Willis">
<DATE DAY="18" MONTH="4" YEAR="2012"/>
<DESCRIPTION>
<P>One ongoing study identified</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2012-04-18 16:20:15 +1000" MODIFIED_BY="[Empty name]">
<DATE DAY="18" MONTH="4" YEAR="2012"/>
<DESCRIPTION>
<P>Updated electronic search strategies; risk of bias assessment tool used; PRISMA flowchart included.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2012-04-18 08:55:56 +1000" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2012-04-18 08:55:56 +1000" MODIFIED_BY="Narelle S Willis">
<DATE DAY="15" MONTH="10" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2012-03-08 11:07:01 +1100" MODIFIED_BY="Narelle S Willis">
<INTERNAL_SOURCES MODIFIED="2012-03-08 11:06:46 +1100" MODIFIED_BY="Narelle S Willis">
<SOURCE MODIFIED="2012-03-08 11:06:46 +1100" MODIFIED_BY="Narelle S Willis">
<NAME>Chinese Cochrane Centre, Chinese Centre of Evidence-based Medicine, West China Hospital of Sichuan University</NAME>
<COUNTRY CODE="CN">China</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES MODIFIED="2012-03-08 11:07:01 +1100" MODIFIED_BY="Narelle S Willis">
<SOURCE MODIFIED="2012-03-08 11:07:01 +1100" MODIFIED_BY="Narelle S Willis">
<NAME>China Medical Board of New York (Grant number:98-680)</NAME>
<COUNTRY CODE="US">USA</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2012-04-18 17:52:38 +1000" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2012-04-18 12:16:29 +1000" MODIFIED_BY="Narelle S Willis">
<TITLE>Increased water intake may help reduce the risk of recurrence of kidney stones but more studies are needed</TITLE>
<SUMMARY_BODY MODIFIED="2012-04-18 12:16:29 +1000" MODIFIED_BY="Narelle S Willis">
<P>Kidney stones (also known as calculi) are masses of crystals and protein and are common causes of urinary tract obstruction in adults. For a long time, increased water intake has been the main preventive measure for the disease and its recurrence. In this review only one study was found that looked at the effect of increase water intake on recurrence and time to recurrence. Increased water intake decreased the chance of recurrence and increased the time to recurrence. Further studies are needed.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2012-04-18 17:50:51 +1000" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2012-04-18 17:50:51 +1000" MODIFIED_BY="Narelle S Willis">
<P>Urinary stones are a common condition characterised by high incidence and high recurrence rate. For a long time, increased water intake has been the main preventive measure for the disease and its recurrence. This is an update of a review originally published in 2004.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2012-04-18 13:55:02 +1000" MODIFIED_BY="Narelle S Willis">
<P>To assess the effectiveness of increased water intake for the primary and secondary prevention of urinary stones.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2012-04-18 16:26:39 +1000" MODIFIED_BY="[Empty name]">
<P>We searched the Cochrane Renal Group's specialised register, CENTRAL, MEDLINE, EMBASE, and the Chinese Biomedical Disk using a search strategy developed in conjunction with Cochrane Renal Group's Trials Search Co-ordinator. No language restriction was applied.<BR/>Date of last search: April 2012.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2012-04-18 16:28:08 +1000" MODIFIED_BY="Narelle S Willis">
<P>Randomised controlled trials (RCTs) and quasi-RCTs of increased water intake for the prevention of urinary stones and its recurrence were included.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2012-04-18 16:28:31 +1000" MODIFIED_BY="[Empty name]">
<P>Two authors independently assessed risk of bias and extracted data. Statistical analyses were performed using the random effects model and the results expressed as risk ratio (RR) for dichotomous outcomes or mean difference (MD) for continuous data with 95% confidence intervals (CI).</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2012-04-18 16:33:08 +1000" MODIFIED_BY="[Empty name]">
<P>No studies of increased water intake for the primary prevention of urinary stones met the inclusion criteria. One study with 199 patients provided results of increased water intake for the recurrence of urinary stones. The stone recurrence was lower in the increased water intake group than that of the no intervention group (12% versus 27%; RR 0.45, 95% CI 0.24 to 0.84). The average interval for recurrence was 3.23 ± 1.1 years in increased water intake group and 2.09 ± 1.37 years in the no intervention group (MD 1.14, 95% CI 0.33 to 1.95). There were insufficient data to assess selection, performance, detection or attrition bias.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2012-04-18 13:57:09 +1000" MODIFIED_BY="Narelle S Willis">
<P>The evidence from only one study indicates that increased water intake reduces the risk of recurrence of urinary stones and prolongs the average interval for recurrences. However further research is required. Due to the lack of appropriate RCTs, no conclusions can be drawn on increased water intake for the primary and secondary prevention of urinary stones.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2012-04-18 17:52:38 +1000" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2012-04-18 16:49:25 +1000" MODIFIED_BY="Narelle S Willis">
<CONDITION MODIFIED="2012-04-18 16:45:28 +1000" MODIFIED_BY="Narelle S Willis">
<P>Urinary stones are a very common urological disease, with the prevalence in the general population estimated to be between 2% and 3%. In China, nationwide surveys held in 1977 and 1983 showed that urinary stones accounted for 26% of all urological patients.</P>
<P>Urinary stones can be divided into upper urinary tract (kidney and ureter) and lower urinary tract (bladder and urethra) stones. Stone formation is a very complex process, and the pathophysiological mechanism is still not fully understood. Currently the treatment options for urinary stones include drug therapy, surgical removal and extracorporeal shock wave lithotripsy (ESWL). However a major problem is the high recurrence rate, even after surgery or ESWL. The natural recurrence rate is reported to be 31.5% after five years and 72% after 20 years (<LINK REF="REF-Ljunghall-1975" TYPE="REFERENCE">Ljunghall 1975</LINK>). The average recurrence rate after surgery and ESWL is 40% after 11 years and 20% after four years (<LINK REF="REF-Kohnmann-1993" TYPE="REFERENCE">Kohnmann 1993</LINK>; <LINK REF="REF-Sutherland-1982" TYPE="REFERENCE">Sutherland 1982</LINK>). The high prevalence and high recurrence rates underscore the importance of a preventive programme.</P>
</CONDITION>
<THEORY MODIFIED="2012-04-18 16:48:06 +1000" MODIFIED_BY="Narelle S Willis">
<P>One of the prevailing assumptions in the literature is that increased water intake and increased urine volume, decreases the incidence of urinary stones in those patients predisposed to the disease. The rationale is that supersaturation of the urinary environment with stone-forming compounds is considered a prerequisite for stone formation. Increased water intake results in excretion of a higher volume of urine, which is less saturated and theoretically benefits all stone-formers. Historical data suggests that increased water intake is effective in preventing stone formation. <LINK REF="REF-Blacklock-1969" TYPE="REFERENCE">Blacklock 1969</LINK> reported that stone formation rates dropped by 86% in the British Navy when the average urinary output was increased from 800 to 1200 mL/d. Experimental evidence (<LINK REF="REF-Pak-1980" TYPE="REFERENCE">Pak 1980</LINK>) indicated that high fluid intake resulted in the reduction of the saturation of calcium phosphate, calcium oxalate and monosodium urate, and increased the threshold at which calcium oxalate crystallised. The authors concluded that there was a protective effect of urine dilution by increased water intake.</P>
</THEORY>
<IMPORTANCE MODIFIED="2012-04-18 16:49:25 +1000" MODIFIED_BY="Narelle S Willis">
<P>Few urologists have tested in a controlled study the preventive effective of increased water intake. <LINK REF="STD-Frank-1966" TYPE="STUDY">Frank 1966</LINK> illustrated its importance in a general population living in a village in a hot desert region, and <LINK REF="STD-Borghi-1996" TYPE="STUDY">Borghi 1996</LINK> demonstrated in a randomised controlled trial (RCT) that a high water intake without dietary change could prolong the interval for recurrence in patients with a history of urinary stones.</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2012-04-18 13:58:48 +1000" MODIFIED_BY="[Empty name]">
<P>This review aims to look at the benefits and harms of:</P>
<OL>
<LI>increased water intake for the primary prevention of urinary stones in a population without a history of the disease; and</LI>
<LI>increased water intake for the secondary prevention of urinary stones in patients with a history of the disease.</LI>
</OL>
</OBJECTIVES>
<METHODS MODIFIED="2012-04-18 17:01:07 +1000" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2012-04-18 16:51:02 +1000" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES MODIFIED="2012-04-18 16:51:02 +1000" MODIFIED_BY="Narelle S Willis">
<P>All RCTs and quasi-RCTs (RCTs in which allocation to treatment was obtained by alternation, use of alternate medical records, date of birth or other predictable methods) looking at the benefits and harms of increased water intake for the prevention of urinary stones and its recurrence. The first period of randomised cross-over studies will be included.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2012-04-18 08:59:00 +1000" MODIFIED_BY="[Empty name]">
<P>All patients with or without a history of urinary stones (all types).<BR/>
</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2012-04-18 14:08:58 +1000" MODIFIED_BY="[Empty name]">
<P>Increased water intake (any kind of water) versus routine care, no intervention or drugs given for more than three months.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2012-04-18 15:43:53 +1000" MODIFIED_BY="[Empty name]">
<OL>
<LI>Incidence of urinary stones</LI>
<LI>Stone recurrence</LI>
<LI>Average interval for recurrence</LI>
<LI>Incidence rate/patient/year</LI>
<LI>Recurrence rate/patient/year</LI>
<LI>Serious adverse effects of the intervention (e.g. water intoxication)</LI>
</OL>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2012-04-18 16:54:28 +1000" MODIFIED_BY="Gail Y Higgins">
<SUBSECTION>
<HEADING LEVEL="3">Initial search</HEADING>
<P>Relevant studies were obtained, with the assistance of the Trials Search Co-ordinator, from the following sources without language restriction (see <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK> for electronic search strategies).</P>
<OL>
<LI>Cochrane Renal Group Specialised Register of Randomised Controlled Trials (January 2004)</LI>
<LI>Cochrane Central Register of Controlled Trials (CENTRAL in <I>The Cochrane Library</I> Issue 2, 2004) for any "New" records not yet incorporated into the specialised register.</LI>
<LI>MEDLINE and Pre-MEDLINE (1966 - January 2004). This will be combined with the Cochrane highly sensitive search strategy for identifying RCTs in MEDLINE (<LINK REF="REF-Dickersin-1994" TYPE="REFERENCE">Dickersin 1994</LINK>), and a similar strategy for EMBASE (<LINK REF="REF-Lefebvre-1996" TYPE="REFERENCE">Lefebvre 1996</LINK>). Please see Cochrane Renal Group Module for details of these strategies</LI>
<LI>EMBASE (1980 - January 2004)</LI>
<LI>Reference lists of nephrology textbooks, review articles and relevant studies.</LI>
<LI>Conference proceedings from nephrology and urology meetings.</LI>
<LI>Letters seeking information about unpublished or incomplete studies to investigators known to be involved in previous studies.</LI>
<LI>The Chinese Biomedical Disk (CBM disk) was also searched to include the Chinese studies.</LI>
</OL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Review update</HEADING>
<P>The Cochrane Renal Group's specialised register was searched for the update of the review in June 2011. The Specialised Register contains studies identified from sources.</P>
<OL>
<LI>Quarterly searches of the Cochrane Central Register of Controlled Trials CENTRAL</LI>
<LI>Weekly searches of MEDLINE (OVID SP)</LI>
<LI>Handsearching of renal-related journals and the proceedings of major renal conferences</LI>
<LI>Searching of the current year of EMBASE (OVID SP)</LI>
<LI>Weekly current awareness alerts for selected renal journals</LI>
<LI>Searches of the International Clinical Trials Register (ICTRP) Search Portal &amp; ClinicalTrials.gov</LI>
</OL>
<P>Studies contained in the specialised register are identified through search strategies for CENTRAL, MEDLINE, and EMBASE based on the scope of the Cochrane Renal Group. Details of these strategies as well as a list of handsearched journals, conference proceedings and current awareness alerts are available in the <I>Specialised Register</I> section of information about the <A HREF="http://onlinelibrary.wiley.com/o/cochrane/clabout/articles/RENAL/frame.html">Cochrane Renal Group</A>.</P>
</SUBSECTION>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2012-04-18 17:01:07 +1000" MODIFIED_BY="[Empty name]">
<STUDY_SELECTION MODIFIED="2012-04-18 12:17:26 +1000" MODIFIED_BY="Narelle S Willis">
<P>The search strategy described was used to obtain titles and abstracts of studies that may be relevant to the review. The titles and abstracts were screened independently by two authors, who discarded studies that were not applicable. However studies and reviews that might include relevant data or information on studies were retained initially. Disagreements were resolved via discussion with a third author.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2012-04-18 16:57:48 +1000" MODIFIED_BY="Narelle S Willis">
<P>Two authors independently assess retrieved abstracts and, where necessary the full text, of these studies to determine which studies satisfied the inclusion criteria. Data extraction was independently carried out using standard data extraction forms. Studies not reported in English or Chinese language journals were translated before assessment. To avoid duplication bias, we focused on checking the author's name, publication date and main results. Where necessary, we extracted data from different publications to obtain all the outcomes. Where more than one publication of one study existed, reports were to be grouped together and the publication with the most complete data used in the analyses. Disagreements were resolved via discussion.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2011-11-14 12:00:22 +1100" MODIFIED_BY="Narelle S Willis">
<P>The following items will be independently assessed by two authors using the risk of bias assessment tool (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>) (<I>see</I> <LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>).</P>
<UL>
<LI>Was there adequate sequence generation (selection bias)?</LI>
<LI>Was allocation adequately concealed (selection bias)?</LI>
<LI>Was knowledge of the allocated interventions adequately prevented during the study (detection bias)?</LI>
<UL>
<LI>Participants and personnel</LI>
<LI>Outcome assessors</LI>
</UL>
<LI>Were incomplete outcome data adequately addressed (attrition bias)?</LI>
<LI>Are reports of the study free of suggestion of selective outcome reporting (reporting bias)?</LI>
<LI>Was the study apparently free of other problems that could put it at a risk of bias?</LI>
</UL>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2012-04-18 13:59:13 +1000" MODIFIED_BY="Narelle S Willis">
<P>For dichotomous outcomes (e.g. stones or no stones) results were expressed as risk ratio (RR) with 95% confidence intervals (CI). Where continuous scales of measurement were used to assess the effects of treatment (e.g. time to stones or interval for recurrence), the mean difference (MD) was used, or the standardised mean difference (SMD) if different scales were used.</P>
</EFFECT_MEASURES>
<MISSING_DATA MODIFIED="2012-04-18 16:59:31 +1000" MODIFIED_BY="Narelle S Willis">
<P>Any further information required from the original author was to be requested and any relevant information obtained was to be included in the review.</P>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2011-11-14 11:55:16 +1100" MODIFIED_BY="Narelle S Willis">
<P>Heterogeneity was to be analysed using a Chi² test on N-1 degrees of freedom, with an alpha of 0.05 used for statistical significance and with the I² test (<LINK REF="REF-Higgins-2003" TYPE="REFERENCE">Higgins 2003</LINK>). I² values of 25%, 50% and 75% correspond to low, medium and high levels of heterogeneity.</P>
</HETEROGENEITY_ASSESSMENT>
<BIAS_ASSESSMENT MODIFIED="2012-04-18 12:15:08 +1000" MODIFIED_BY="Narelle S Willis">
<P>If sufficient RCTs were identified, publication bias was to be investigated using a funnel plot (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>).</P>
</BIAS_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2012-04-18 17:00:13 +1000" MODIFIED_BY="Narelle S Willis">
<P>Data was to be pooled using the random effects model but the fixed effects model was also to be analysed to ensure robustness of the model chosen and susceptibility to outliers</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2012-04-18 17:01:07 +1000" MODIFIED_BY="Narelle S Willis">
<P>Subgroup analysis were to be used to explore possible sources of heterogeneity (e.g. with or without a history of urinary stones; different volumes of water intake; different types of water (e.g. tap water, mineral water); different types of stones (e.g. calcium, uric acid)). Adverse effects were to be tabulated and assessed with descriptive techniques, as they were likely to be different for the various agents used. Where possible, the risk difference (RD) with 95% CI was to be calculated for each adverse effect, either compared to no treatment or to another agent. We also planned to conduct calculation of absolute risk reductions (ARR) for increased water intake versus no intervention or a different intervention.</P>
<P>Subgroup analysis were to be performed if sufficient data was provided for patients with hyperthyroidism, hyperparathyroidism, metabolic stones (e.g. cystinuria, oxalosis), Cushing's syndrome, severe diabetes, gout, urinary infections or other decalcification diseases, as these factors are considered to promote the stone formation process.</P>
</SUBGROUP_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2012-04-18 17:52:38 +1000" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2012-04-18 17:03:02 +1000" MODIFIED_BY="[Empty name]">
<P>Despite extensive literature searching, no study of increased water intake for the primary prevention of urinary stones met our inclusion criteria. Only one RCT of increased water intake for preventing the recurrence of urinary stones fulfilled our inclusion criteria (<LINK REF="STD-Borghi-1996" TYPE="STUDY">Borghi 1996</LINK>). This study randomised 220 patients to control group (just drink water as usual) and intervention group (a high water intake which would give a urine volume equal to or greater than 2 L/d). The number of patients that completed the study with a follow-up of five years was 199 (99 in the intervention group and 100 in control group). </P>
<P>Further information about the electronic searching is presented in the study flow diagram (<LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>).</P>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2012-04-18 17:47:29 +1000" MODIFIED_BY="[Empty name]">
<ALLOCATION MODIFIED="2012-04-18 17:31:52 +1000" MODIFIED_BY="[Empty name]">
<P>The method of random sequence generation and allocation concealment was not described.</P>
</ALLOCATION>
<BLINDING MODIFIED="2012-04-18 17:31:11 +1000" MODIFIED_BY="[Empty name]">
<P>Blinding was not possible for participants and investigators and not reported for outcome assessors.</P>
</BLINDING>
<EXCLUSIONS MODIFIED="2012-03-08 11:03:02 +1100" MODIFIED_BY="[Empty name]">
<P>The dropout was 9.5%. No intention-to-treat analysis was performed.</P>
</EXCLUSIONS>
<SELECTIVE_REPORTING MODIFIED="2012-04-18 17:47:29 +1000" MODIFIED_BY="[Empty name]">
<P>Only two of our six of our predefined outcomes were reported, and further information could not be obtained from the investigators.</P>
</SELECTIVE_REPORTING>
<OTHER_BIAS_SOURCES MODIFIED="2012-04-18 17:47:02 +1000" MODIFIED_BY="[Empty name]">
<P>Insufficient information was provided to determine if there were any other potential sources of bias.</P>
<P>Risk of bias assessment is summarised in <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK> and <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>.</P>
</OTHER_BIAS_SOURCES>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2012-04-18 17:52:38 +1000" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">Stone recurrence and average time to recurrence</HEADING>
<P>Stone recurrence was lower in the increased water intake group (12%) than that of the no intervention group (27%) (<LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>: RR 0.45, 95% CI 0.24 to 0.84). The average time to recurrences was 3.23 ± 1.1 years in increased water intake group and 2.09 ± 1.37 years in the control group (<LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>: MD 1.14, 95% CI 0.33 to 1.95).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Adverse effects</HEADING>
<P>Adverse effects where not reported.</P>
<P>The other planned outcomes and subgroup analyses could not be performed because of the lack of appropriate studies.</P>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2012-04-18 17:38:05 +1000" MODIFIED_BY="[Empty name]">
<SUMMARY_OF_RESULTS MODIFIED="2012-04-18 17:13:51 +1000" MODIFIED_BY="[Empty name]">
<P>Despite the fact that increased water intake has been widely used to prevent urinary stones and its recurrence, no RCTs were found investigating increased water intake for the prevention of urinary stones.</P>
<P>With regard to the prevention of recurrences in stone formers, only one study met our inclusion criteria. It reported stone recurrence was lower (RR 0.45, 95% CI 0.24 to 0.84) and average time to recurrence was longer for the increased water intake group (MD 1.14, 95% CI 0.33 to 1.95). Blinding and the method of randomisation were unclear and so the results must be considered with some caution. Confirmatory research is required.</P>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2012-04-18 17:26:24 +1000" MODIFIED_BY="[Empty name]">
<P>
<LINK REF="STD-Borghi-1996" TYPE="STUDY">Borghi 1996</LINK> applied no restrictions with respect to age, body weight, occupation or comorbidities. However this conclusion need further conformation with more RCTs.</P>
<P>Urinary stones are a global health issue permeating all geographic regions and socioeconomic classes, and have an increasing incidence and high recurrence rate. Drinking water remains a simple and cost-effective preventive method, and is recommended by most healthcare facilities. This review sought to confirm these recommendations by analysing RCT evidence and to determine the direction and strength of this evidence.</P>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2012-04-18 17:36:55 +1000" MODIFIED_BY="[Empty name]">
<P>Only one RCT enrolling 220 participants with a follow-up period of five years was included. The method of randomisation and allocation concealment was not described; blinding of participants and investigators was not possible, and blinding of outcome assessors was not reported. Eleven patients dropped out without explanation (dropout rate 9.5%) and intention-to-treat analysis was not performed. There was no evidence of selective outcome reporting, although no potential adverse events were reported.</P>
</QUALITY_OF_EVIDENCE>
<POTENTIAL_BIASES MODIFIED="2012-04-18 12:18:29 +1000" MODIFIED_BY="[Empty name]">
<P>We followed the Cochrane Collaboration guidelines for conducting this systematic review and meta-analysis. Strengths of our review include the searching of several databases with no language restrictions. Study selection, assessment of risk of bias, and data extraction were performed by two authors, which reduced the risk of error and bias. Although efforts were made to collect relevant data, the possibility of missing data cannot be excluded. Publication bias remains a possible source of important bias. Meanwhile, interpretation of the result should be done cautiously because the number of studies included in relation to our selection criteria was limited.</P>
</POTENTIAL_BIASES>
<AGREEMENT MODIFIED="2012-04-18 17:38:05 +1000" MODIFIED_BY="[Empty name]">
<P>We are not aware of any other systematic reviews on this topic; however two observational studies support the effectiveness of increased water intake for the prevention of urinary stones (<LINK REF="STD-Curhan-1993" TYPE="STUDY">Curhan 1993</LINK>; <LINK REF="STD-Frank-1966" TYPE="STUDY">Frank 1966</LINK>). <LINK REF="STD-Frank-1966" TYPE="STUDY">Frank 1966</LINK> compared the incidence of urinary stones in two desert towns after an educational program had been run in one of them for increasing water intake as a preventive measure against the risk of urinary stones. After three years the prevalence of urinary stones was lower in the intervention town (0.28% versus 0.85%, P &lt; 0.001). This finding has been confirmed in a wide ranging, long-term study in the US (<LINK REF="STD-Curhan-1993" TYPE="STUDY">Curhan 1993</LINK>). In this study, a total of 45,619 male health professionals aged 40 to 75 years with no history of urinary stones were enrolled. Daily fluid intake was divided into quintiles and the RR of kidney stone development decreased with increased fluid consumption: (&lt; 1275 mL, RR = 1.0; 1275 to 1669 mL, RR = 1.05; 1670 to 2049 mL, RR = 0.82; 2050 to 2537 mL, RR = 0.72; &gt; 2537 mL, RR = 0.52).</P>
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2012-04-18 17:39:09 +1000" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2012-04-18 15:38:02 +1000" MODIFIED_BY="Narelle S Willis">
<P>No evidence is available for the benefit of increasing water intake for the primary prevention of urinary stones. There is inconclusive evidence of the benefit of increasing water intake for the secondary prevention of urinary stones. However no implications for practice are warranted in light of the small amount of available evidence.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2012-04-18 17:39:09 +1000" MODIFIED_BY="[Empty name]">
<UL>
<LI>Large, multi-centre long-term RCTs of good quality are required to answer the questions concerning increased water intake for the primary and secondary prevention of urinary stones.</LI>
<LI>Future studies should be designed to evaluate how much water and what kind of water is best for the primary and secondary prevention of urinary stones.</LI>
<LI>The effect of increased water intake on different kinds of stone formers should also be evaluated.</LI>
</UL>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2012-04-18 17:39:24 +1000" MODIFIED_BY="[Empty name]">
<UL>
<LI>The authors would like to thank Zhang Ke who contributed to the design, quality assessment, data collection, entry, analysis and interpretation, and writing of the initial version (<LINK REF="REF-Ke-2004" TYPE="REFERENCE">Ke 2004</LINK>) of this review.</LI>
<LI>The authors are grateful for the help and support of Narelle Willis, Managing Editor; and Gail Higgins, Trials Search Co-ordinator, and all the personnel from Cochrane Renal Group.</LI>
</UL>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST>
<P>We certify that we have no affiliations with or involvement in any organization or entity with a direct financial interest in the subject matter of the review (e.g. employment, consultancy, stock ownership).</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2012-04-18 11:45:29 +1000" MODIFIED_BY="[Empty name]">
<UL>
<LI>BY: updating the review, selection of studies, risk of bias assessment, data extraction, data analysis</LI>
<LI>WQ: writing and updating review, selection of studies, risk of bias assessment, data extraction, data analysis</LI>
</UL>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2011-11-14 11:54:28 +1100" MODIFIED_BY="Narelle S Willis">
<UL>
<LI>Risk of bias assessment tool has replaced the quality assessment checklist (<LINK REF="REF-Wei-2003" TYPE="REFERENCE">Wei 2003</LINK>).</LI>
<LI>I² statistic was used to assess heterogeneity (<LINK REF="REF-Higgins-2003" TYPE="REFERENCE">Higgins 2003</LINK>)</LI>
</UL>
</PRO_REV_DIFF>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2012-04-18 16:09:25 +1000" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2012-04-18 16:09:25 +1000" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2012-04-18 15:32:05 +1000" MODIFIED_BY="Narelle S Willis">
<STUDY DATA_SOURCE="PUB" ID="STD-Borghi-1996" MODIFIED="2012-04-18 15:32:05 +1000" MODIFIED_BY="Narelle S Willis" NAME="Borghi 1996" YEAR="1996">
<REFERENCE MODIFIED="2012-04-18 15:32:05 +1000" MODIFIED_BY="Narelle S Willis" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Borghi L, Meschi T, Amato F, Briganti A, Novarini A, Giannini A</AU>
<TI>Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study</TI>
<SO>Journal of Urology</SO>
<YR>1996</YR>
<VL>155</VL>
<NO>3</NO>
<PG>839-43</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="8583588"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2012-04-18 16:09:25 +1000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Curhan-1993" NAME="Curhan 1993" YEAR="1993">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Curhan GC, Willett WC, Rimm EB, Stampfer MJ</AU>
<TI>A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones</TI>
<SO>New England Journal of Medicine</SO>
<YR>1993</YR>
<VL>328</VL>
<NO>12</NO>
<PG>833-8</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="8441427"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-de-La-Gu_x00e9_ronni_x00e8_re-2011" MODIFIED="2012-04-18 14:21:28 +1000" MODIFIED_BY="Narelle S Willis" NAME="de La Guéronnière 2011" YEAR="2011">
<REFERENCE MODIFIED="2012-04-18 14:21:28 +1000" MODIFIED_BY="Narelle S Willis" PRIMARY="NO" TYPE="OTHER">
<AU>de La Guéronnière V, Le Bellego L, Jimenez IB, Dohein O, Tack I, Daudon M</AU>
<TI>Increasing water intake by 2 liters reduces crystallization risk indexes in healthy subjects</TI>
<SO>Archivio Italiano di Urologia, Andrologia</SO>
<YR>2011</YR>
<VL>83</VL>
<NO>1</NO>
<PG>43-50</PG>
<IDENTIFIERS MODIFIED="2012-04-18 14:21:28 +1000" MODIFIED_BY="Narelle S Willis">
<IDENTIFIER MODIFIED="2012-04-18 14:21:28 +1000" MODIFIED_BY="Narelle S Willis" TYPE="MEDLINE" VALUE="21585170"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Di-Silverio-1994" MODIFIED="2012-04-18 16:06:35 +1000" MODIFIED_BY="[Empty name]" NAME="Di Silverio 1994" YEAR="1994 Dec">
<REFERENCE MODIFIED="2012-04-18 16:06:35 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Di Silverio F, D'Angelo AR</AU>
<TI>Prevention of renal calculosis: efficacy of Fiuggi water cure. Research Group on Renal Calculosis</TI>
<SO>Archivio Italiano di Urologia, Andrologia</SO>
<YR>1994</YR>
<VL>66</VL>
<NO>5</NO>
<PG>253-8</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="7812305"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Di-Silverio-2000" MODIFIED="2011-12-04 00:00:02 +1100" MODIFIED_BY="[Empty name]" NAME="Di Silverio 2000" YEAR="2000">
<REFERENCE MODIFIED="2011-12-04 00:00:02 +1100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Di Silverio F, Ricciuti GP, D'Angelo AR, Fraioli A, Simeoni G</AU>
<TI>Stone recurrence after lithotripsy in patients with recurrent idiopathic calcium urolithiasis: Efficacy of treatment with Fiuggi water</TI>
<SO>European Urology</SO>
<YR>2000</YR>
<VL>37</VL>
<NO>2</NO>
<PG>145-8</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="EMBASE" VALUE="2000069669"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Frank-1966" MODIFIED="2012-04-18 15:32:05 +1000" MODIFIED_BY="Narelle S Willis" NAME="Frank 1966" YEAR="1966">
<REFERENCE MODIFIED="2012-04-18 15:32:05 +1000" MODIFIED_BY="Narelle S Willis" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Frank M, De Vries A, Tikva P</AU>
<TI>Prevention of urolithiasis. Education to adequate fluid intake in a new town situated in the Judean Desert Mountains</TI>
<SO>Archives of Environmental Health</SO>
<YR>1966</YR>
<VL>13</VL>
<NO>3</NO>
<PG>625-30</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="5925636"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Karagulle-2007" MODIFIED="2011-12-04 00:00:07 +1100" MODIFIED_BY="[Empty name]" NAME="Karagulle 2007" YEAR="2007 Jun">
<REFERENCE MODIFIED="2011-12-04 00:00:07 +1100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Karagulle O, Smorag U, Candir F, Gundermann G, Jonas U, Becker AJ, et al</AU>
<TI>Clinical study on the effect of mineral waters containing bicarbonate on the risk of urinary stone formation in patients with multiple episodes of CaOx-urolithiasis</TI>
<SO>World Journal of Urology</SO>
<YR>2007</YR>
<VL>25</VL>
<NO>3</NO>
<PG>315-23</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="17333204"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lorentzen-1979" MODIFIED="2012-04-18 16:09:25 +1000" MODIFIED_BY="[Empty name]" NAME="Lorentzen 1979" YEAR="1979 Feb 26">
<REFERENCE MODIFIED="2012-04-18 16:09:25 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lorentzen JE, Lund F, Andersen B, Dorph S</AU>
<TI>Effect of Radison water in treatment of patients with renal calculi. A randomized double-blind method</TI>
<SO>Ugeskrift for Laeger</SO>
<YR>1979</YR>
<VL>141</VL>
<NO>9</NO>
<PG>579-81</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="371092"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Marangella-1996" MODIFIED="2011-12-04 00:00:12 +1100" MODIFIED_BY="[Empty name]" NAME="Marangella 1996" YEAR="1996 Sep">
<REFERENCE MODIFIED="2011-12-04 00:00:11 +1100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Marangella M, Vitale C, Petrarulo M, Rovera L, Dutto F</AU>
<TI>Effects of mineral composition of drinking water on risk for stone formation and bone metabolism in idiopathic calcium nephrolithiasis</TI>
<SO>Clinical Science</SO>
<YR>1996</YR>
<VL>91</VL>
<NO>3</NO>
<PG>313-8</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="8869414"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Neimark-2003" MODIFIED="2012-04-18 14:20:45 +1000" MODIFIED_BY="[Empty name]" NAME="Neimark 2003" YEAR="2003 Jul">
<REFERENCE MODIFIED="2012-04-18 14:20:45 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Neimark AI, Davydov AV</AU>
<TI>Use of "Serebrianyi Kliuch" mineral water in the postoperative treatment of patients with nephrolithiasis after extracorporeal shock-wave lithotripsy</TI>
<SO>Urologiia (Moscow, Russia)</SO>
<YR>2003</YR>
<NO>4</NO>
<PG>44-6</PG>
<IDENTIFIERS MODIFIED="2012-04-18 14:20:45 +1000" MODIFIED_BY="Narelle S Willis">
<IDENTIFIER MODIFIED="2012-04-18 14:20:45 +1000" MODIFIED_BY="Narelle S Willis" TYPE="MEDLINE" VALUE="12942727"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rodgers-1998" MODIFIED="2011-12-04 00:00:12 +1100" MODIFIED_BY="[Empty name]" NAME="Rodgers 1998" YEAR="1998 Apr">
<REFERENCE MODIFIED="2011-12-04 00:00:11 +1100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rodgers AL</AU>
<TI>The influence of South African mineral water on reduction of risk of calcium oxalate kidney stone formation</TI>
<SO>South African Medical Journal</SO>
<YR>1998</YR>
<VL>88</VL>
<NO>4</NO>
<PG>448-51</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="9594989"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Valli-2000" MODIFIED="2012-04-18 16:07:09 +1000" MODIFIED_BY="[Empty name]" NAME="Valli 2000" YEAR="2000 Apr">
<REFERENCE MODIFIED="2012-04-18 16:07:09 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Valli PP, Cesaroni M, Mearini L, Rociola W, Cervelli B, Porena M</AU>
<TI>Hyperhydration with low mineral Rocchetta water after extracorporeal lithotripsy</TI>
<SO>Archivio Italiano di Urologia, Andrologia</SO>
<YR>2000</YR>
<VL>72</VL>
<NO>1</NO>
<PG>29-31</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="10875164"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2011-12-04 00:00:12 +1100" MODIFIED_BY="[Empty name]"/>
<ONGOING_STUDIES MODIFIED="2012-04-18 14:22:46 +1000" MODIFIED_BY="Gail Y Higgins">
<STUDY DATA_SOURCE="PUB" ID="STD-Borghi-2010" MODIFIED="2012-04-18 14:22:46 +1000" MODIFIED_BY="Gail Y Higgins" NAME="Borghi 2010" YEAR="2010">
<REFERENCE MODIFIED="2012-04-18 14:22:46 +1000" MODIFIED_BY="Gail Y Higgins" PRIMARY="NO" TYPE="OTHER">
<AU>Borghi L</AU>
<TI>The links between water and salt intake, body weight, hypertension and kidney stones: a difficult puzzle</TI>
<SO>clinicaltrials.gov/ct2/show/NCT01100580</SO>
<YR>(accessed 18 April 2012)</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2011-05-30 17:25:13 +1000" MODIFIED_BY="Gail Y Higgins">
<IDENTIFIER MODIFIED="2011-05-30 17:25:13 +1000" MODIFIED_BY="Gail Y Higgins" TYPE="CTG" VALUE="NCT01100580"/>
</IDENTIFIERS>
</STUDY>
</ONGOING_STUDIES>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2012-04-18 13:43:05 +1000" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2012-04-18 13:43:05 +1000" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Blacklock-1969" NAME="Blacklock 1969" TYPE="BOOK">
<AU>Blacklock NJ</AU>
<TI>The pattern of urolithiasis in the Royal Navy</TI>
<SO>Proceedings of the renal stone research symposium</SO>
<YR>1969</YR>
<PG>33-47</PG>
<ED>Hodgkinson A, Nordin BEC</ED>
<PB>J&amp;A Churchill LTD</PB>
<CY>London</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Dickersin-1994" MODIFIED="2008-10-15 18:00:25 +1100" MODIFIED_BY="[Empty name]" NAME="Dickersin 1994" TYPE="JOURNAL_ARTICLE">
<AU>Dickersin K, Scherer R, Lefebvre C</AU>
<TI>Identifying relevant studies for systematic reviews</TI>
<SO>BMJ</SO>
<YR>1994</YR>
<VL>309</VL>
<NO>6964</NO>
<PG>1286-91</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="7718048"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2003" MODIFIED="2011-11-14 11:53:56 +1100" MODIFIED_BY="Narelle S Willis" NAME="Higgins 2003" TYPE="JOURNAL_ARTICLE">
<AU>Higgins JP, Thompson SG, Deeks JJ, Altman DG</AU>
<TI>Measuring inconsistency in meta-analyses</TI>
<SO>BMJ</SO>
<YR>2003</YR>
<VL>327</VL>
<NO>7414</NO>
<PG>557-60</PG>
<IDENTIFIERS MODIFIED="2011-11-14 11:53:51 +1100" MODIFIED_BY="Narelle S Willis">
<IDENTIFIER TYPE="MEDLINE" VALUE="12958120"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011" MODIFIED="2012-04-18 13:43:05 +1000" MODIFIED_BY="Narelle S Willis" NAME="Higgins 2011" TYPE="OTHER">
<AU>Higgins JPT, Green S (editors)</AU>
<TI>Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011</TI>
<SO>Available from www.cochrane-handbook.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kohnmann-1993" NAME="Kohnmann 1993" TYPE="JOURNAL_ARTICLE">
<AU>Kohrmann KU, Rassweiler J, Alken P</AU>
<TI>The recurrence rate of stones following ESWL</TI>
<SO>World Journal of Urology</SO>
<YR>1993</YR>
<VL>11</VL>
<NO>1</NO>
<PG>26-30</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="93258437"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Lefebvre-1996" NAME="Lefebvre 1996" TYPE="OTHER">
<AU>Lefebvre C, McDonald S</AU>
<TI>Development of a sensitive search strategy for reports of randomised controlled trials in EMBASE</TI>
<SO>Fourth International Cochrane Colloquium; 1996 Oct 20-24; Adelaide (Australia)</SO>
<YR>1996</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ljunghall-1975" NAME="Ljunghall 1975" TYPE="JOURNAL_ARTICLE">
<AU>Ljunghall S, Hedstrand H</AU>
<TI>Epidemiology of renal stones in a middle-aged male population</TI>
<SO>Acta Medica Scandinavica</SO>
<YR>1975</YR>
<VL>197</VL>
<NO>6</NO>
<PG>439-45</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Pak-1980" MODIFIED="2008-10-15 18:00:33 +1100" MODIFIED_BY="[Empty name]" NAME="Pak 1980" TYPE="JOURNAL_ARTICLE">
<AU>Pak CY, Sakhaee K, Crowther C, Brinkley L</AU>
<TI>Evidence justifying a high fluid intake in treatment of nephrolithiasis</TI>
<SO>Annals of Internal Medicine</SO>
<YR>1980</YR>
<VL>93</VL>
<NO>1</NO>
<PG>36-9</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="80240234"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Sutherland-1982" MODIFIED="2008-10-15 18:00:35 +1100" MODIFIED_BY="[Empty name]" NAME="Sutherland 1982" TYPE="JOURNAL_ARTICLE">
<AU>Sutherland JW</AU>
<TI>Recurrence following operative treatment of upper urinary tract stone</TI>
<SO>Journal of Urology</SO>
<YR>1982</YR>
<VL>127</VL>
<NO>3</NO>
<PG>472-4</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="82145743"/>
</IDENTIFIERS>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2012-03-08 10:59:32 +1100" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Ke-2004" MODIFIED="2012-03-08 10:59:32 +1100" MODIFIED_BY="Narelle S Willis" NAME="Ke 2004" TYPE="COCHRANE_REVIEW">
<AU>Ke Z, Wei Q</AU>
<TI>Water for preventing urinary calculi</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2004</YR>
<NO>3</NO>
<IDENTIFIERS MODIFIED="2012-03-08 10:59:21 +1100" MODIFIED_BY="Narelle S Willis">
<IDENTIFIER MODIFIED="2012-03-08 10:59:21 +1100" MODIFIED_BY="Narelle S Willis" TYPE="DOI" VALUE="10.1002/14651858.CD004292.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Wei-2003" MODIFIED="2008-10-15 18:06:06 +1100" MODIFIED_BY="[Empty name]" NAME="Wei 2003" TYPE="COCHRANE_PROTOCOL">
<AU>Wei Q, Zhang K</AU>
<TI>Water for preventing urinary calculi</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2003</YR>
<NO>3</NO>
<IDENTIFIERS MODIFIED="2008-10-15 18:06:03 +1100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2008-10-15 18:06:03 +1100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD004292"/>
</IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2012-04-24 10:38:19 +1000" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2012-04-18 17:46:08 +1000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2012-04-18 15:47:22 +1000" MODIFIED_BY="Narelle S Willis" STUDY_ID="STD-Borghi-1996">
<CHAR_METHODS MODIFIED="2012-04-18 11:27:51 +1000" MODIFIED_BY="Narelle S Willis">
<UL>
<LI>Study design: prospective RCT</LI>
<LI>Study duration: started 1996, with 5 year follow-up</LI>
</UL>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-04-18 11:40:25 +1000" MODIFIED_BY="Narelle S Willis">
<UL>
<LI>Setting: Single centre</LI>
<LI>Country: Italy</LI>
<LI>Patients with first episode of idiopathic calcium nephrolithiasis (calculus found at the chemical examination to be composed of pure calcium oxalate or mixed with traces of calcium phosphate),absence of other retained calculi (renal echography and IVP) and absence of arterial hypertension or other metabolic pathology that requires regular dietary measures or drug therapy</LI>
<LI>Number: 220 enrolled, 199 analysed</LI>
<UL>
<LI>Group 1: 99</LI>
<LI>Group 2: 100</LI>
</UL>
<LI>Mean age ± SD years: group 1 (42.2 ± 11.6); group 2 (40.4 ± 13.2)</LI>
<LI>Sex (M/F): group 1 (70/29); group 2 (64/36)</LI>
</UL>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-04-18 11:43:24 +1000" MODIFIED_BY="Narelle S Willis">
<P>Group 1</P>
<UL>
<LI>A high water intake which would give a urine volume equal to or greater than 2L/d</LI>
</UL>
<P>Group 2</P>
<UL>
<LI>No treatment</LI>
</UL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-04-18 15:47:22 +1000" MODIFIED_BY="Narelle S Willis">
<UL>
<LI>Recurrence</LI>
<LI>Average interval for recurrence</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-04-18 12:18:06 +1000" MODIFIED_BY="Narelle S Willis">
<P>Baseline of the intervention group, including urine volume, creatine, urea etc, is equal to that of the control group.</P>
<P>During the study period, urine volume of the intervention group was significantly greater than that of the control group (2621 ± 443 mL/24 h versus 1014 ± 195 mL/24 h, P &lt; 0.0001).</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2012-04-18 15:47:32 +1000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2012-04-18 09:01:14 +1000" MODIFIED_BY="Narelle S Willis" STUDY_ID="STD-Curhan-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-04-18 09:01:14 +1000" MODIFIED_BY="Narelle S Willis">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-04-18 14:13:17 +1000" MODIFIED_BY="Narelle S Willis" STUDY_ID="STD-de-La-Gu_x00e9_ronni_x00e8_re-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-04-18 14:13:17 +1000" MODIFIED_BY="Narelle S Willis">
<P>Intervention given for only 6 days</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-04-18 15:47:30 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Di-Silverio-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-04-18 15:47:30 +1000" MODIFIED_BY="[Empty name]">
<P>Results not presented for recurrence</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-12-07 23:51:18 +1100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Di-Silverio-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-12-07 23:51:18 +1100" MODIFIED_BY="[Empty name]">
<P>Wrong comparator</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-12-08 00:07:19 +1100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Frank-1966">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-12-08 00:07:19 +1100" MODIFIED_BY="[Empty name]">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-12-08 00:06:54 +1100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Karagulle-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-12-08 00:06:54 +1100" MODIFIED_BY="[Empty name]">
<P>Wrong comparator</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-12-08 01:41:41 +1100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lorentzen-1979">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-12-08 01:41:41 +1100" MODIFIED_BY="[Empty name]">
<P>Wrong comparator</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-04-18 09:01:21 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Marangella-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-04-18 09:01:21 +1000" MODIFIED_BY="[Empty name]">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-12-08 18:07:52 +1100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Neimark-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-12-08 18:07:52 +1100" MODIFIED_BY="[Empty name]">
<P>Wrong comparator</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-04-18 15:47:32 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Rodgers-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-04-18 15:47:32 +1000" MODIFIED_BY="[Empty name]">
<P>Results not presented for recurrence</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-12-08 18:09:56 +1100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Valli-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-12-08 18:09:56 +1100" MODIFIED_BY="[Empty name]">
<P>Wrong comparator</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2011-12-04 00:00:12 +1100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES MODIFIED="2012-04-24 10:38:19 +1000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<ONGOING_CHAR MODIFIED="2012-04-24 10:38:19 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Borghi-2010">
<CHAR_STUDY_NAME MODIFIED="2011-12-09 14:44:51 +1100" MODIFIED_BY="[Empty name]">
<P>The Links Between Water and Salt Intake, Body Weight, Hypertension and Kidney Stones: a Difficult Puzzle</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2012-03-08 11:06:20 +1100" MODIFIED_BY="[Empty name]">
<P>Prospective, randomised, open label, Interventional study</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-04-18 09:01:41 +1000" MODIFIED_BY="[Empty name]">
<P>For stone formers main inclusion criteria</P>
<UL>
<LI>age between 20 and 70 years</LI>
<LI>Caucasian race</LI>
<LI>idiopathic calcium stone disease</LI>
<LI>normal renal function (creatininemia &lt;1.2 mg/dL)</LI>
</UL>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-03-08 11:18:42 +1100" MODIFIED_BY="[Empty name]">
<P>Dietary supplement: low salt diet + water therapy</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-03-08 11:14:16 +1100" MODIFIED_BY="[Empty name]">
<P>Primary outcome</P>
<UL>
<LI>Normalization of urinary stone risk factors</LI>
</UL>
<P>Secondary outcomes</P>
<UL>
<LI>urinary sodium/calcium relationship</LI>
<LI>blood pressure reduction</LI>
<LI>relationship between 24h-calciuria and blood pressure</LI>
<LI>stone rate reduction</LI>
<LI>correlation BMI-urinary stone risk factors</LI>
<LI>compliance</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2011-12-09 14:50:55 +1100" MODIFIED_BY="[Empty name]">
<P>May 2010</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2012-04-24 10:38:19 +1000" MODIFIED_BY="[Empty name]">
<P>Prof Loris Borghi +390521703375 loris.borghi@unipr.it</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2012-03-08 11:10:14 +1100" MODIFIED_BY="[Empty name]">
<P>Study not yet recruiting (March 2012)</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2012-04-18 17:46:08 +1000" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2011-11-10 22:55:31 +1100" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-11-10 22:55:31 +1100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Borghi-1996">
<DESCRIPTION>
<P>Insufficient information about the sequence generation process</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2011-11-10 22:06:08 +1100" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-11-10 22:06:08 +1100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Borghi-1996">
<DESCRIPTION>
<P>Method of concealment is not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2012-04-18 09:00:38 +1000" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1" REF_IDS="CMP-001.01 CMP-001.02">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" MODIFIED="2011-11-10 22:44:43 +1100" MODIFIED_BY="[Empty name]" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-07.01" NO="1" REF_IDS="CMP-001.01 CMP-001.02">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2011-11-10 22:44:43 +1100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Borghi-1996">
<DESCRIPTION>
<P>Insufficient information to permit judgement of &#8216;Low risk&#8217; or &#8216;High risk&#8217;</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" MODIFIED="2011-11-10 22:44:44 +1100" MODIFIED_BY="[Empty name]" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-08.01" NO="1" REF_IDS="CMP-001.01 CMP-001.02">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-11-10 22:44:44 +1100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Borghi-1996">
<DESCRIPTION>
<P>Insufficient information to permit judgement of &#8216;Low risk&#8217; or &#8216;High risk&#8217;</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2012-04-18 12:09:51 +1000" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1" REF_IDS="CMP-001.01 CMP-001.02">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-04-18 12:09:51 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Borghi-1996">
<DESCRIPTION>
<P>Dropout rate &lt; 10%, intention-to-treat analysis was not performed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2012-04-18 17:46:08 +1000" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-04-18 17:46:08 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Borghi-1996">
<DESCRIPTION>
<P>Only two of our six predefined outcomes were reported and we were unable to obtain any additional data from the authors.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2011-11-10 23:52:22 +1100" MODIFIED_BY="[Empty name]"/>
<ADDITIONAL_TABLES MODIFIED="2011-05-30 17:26:23 +1000" MODIFIED_BY="Gail Y Higgins"/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2012-04-18 15:43:05 +1000" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2012-04-18 15:43:05 +1000" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Increased water intake versus standard water intake</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="12" EVENTS_2="27" I2="0.0" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2012-04-18 15:43:05 +1000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="5.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="99" TOTAL_2="100" WEIGHT="0.0" Z="0.0">
<NAME>Stone recurrence</NAME>
<GROUP_LABEL_1>Increased intake</GROUP_LABEL_1>
<GROUP_LABEL_2>Standard intake</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours increased</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours standard</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.8350608616088037" CI_START="0.24134952328190062" EFFECT_SIZE="0.4489337822671156" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="27" LOG_CI_END="-0.07828187074678689" LOG_CI_START="-0.6173535546710379" LOG_EFFECT_SIZE="-0.3478177127089124" ORDER="19757" O_E="0.0" SE="0.31665337558497664" STUDY_ID="STD-Borghi-1996" TOTAL_1="99" TOTAL_2="100" VAR="0.10026936026936027" WEIGHT="0.0"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-001.02" MODIFIED="2012-04-18 15:42:08 +1000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="2.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="12" TOTAL_2="27" UNITS="years" WEIGHT="0.0" Z="0.0">
<NAME>Average interval for recurrence</NAME>
<GROUP_LABEL_1>Increased intake</GROUP_LABEL_1>
<GROUP_LABEL_2>Standard intake</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours increased</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours standard</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.948940910260208" CI_START="0.33105908973979226" EFFECT_SIZE="1.1400000000000001" ESTIMABLE="YES" MEAN_1="3.23" MEAN_2="2.09" ORDER="19758" SD_1="1.1" SD_2="1.37" SE="0.41273253827163686" STUDY_ID="STD-Borghi-1996" TOTAL_1="12" TOTAL_2="27" WEIGHT="0.0"/>
</CONT_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2012-04-18 17:46:09 +1000" MODIFIED_BY="Narelle S Willis">
<FIGURE FILENAME="Flowchart.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2012-04-18 14:14:35 +1000" MODIFIED_BY="Narelle S Willis" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Study flow diagram.</P>
</CAPTION>
<FILE>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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2012-04-18 17:46:09 +1000" MODIFIED_BY="Narelle S Willis" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION>
<P>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.</P>
</CAPTION>
<FILE>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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-03" MODIFIED="2012-04-18 17:46:09 +1000" MODIFIED_BY="Narelle S Willis" NO="3" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>Risk of bias summary: review authors' judgements about each risk of bias item for each included study.</P>
</CAPTION>
<FILE>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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2011-12-20 19:21:11 +1100" MODIFIED_BY="Gail Y Higgins">
<APPENDIX ID="APP-01" MODIFIED="2011-12-20 19:21:11 +1100" MODIFIED_BY="Gail Y Higgins" NO="1">
<TITLE MODIFIED="2011-05-30 17:14:05 +1000" MODIFIED_BY="Gail Y Higgins">Electronic search strategies</TITLE>
<APPENDIX_BODY MODIFIED="2011-12-20 19:21:11 +1100" MODIFIED_BY="Gail Y Higgins">
<TABLE COLS="2" ROWS="3">
<TR>
<TH>
<P>DATABASE</P>
</TH>
<TH>
<P>Search terms</P>
</TH>
</TR>
<TR>
<TD VALIGN="TOP">
<P>CENTRAL</P>
</TD>
<TD>
<OL>
<LI>MeSH descriptor Water, this term only</LI>
<LI>MeSH descriptor Drinking, this term only</LI>
<LI>MeSH descriptor Fluid Therapy, this term only</LI>
<LI>MeSH descriptor Body Water, this term only</LI>
<LI>MeSH descriptor Beverages, this term only</LI>
<LI>(water*):ti,ab,kw in Clinical Trials</LI>
<LI>(fluid*):ti,ab,kw in Clinical Trials</LI>
<LI>(drink*):ti,ab,kw in Clinical Trials</LI>
<LI>(#1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8)</LI>
<LI>MeSH descriptor Urinary Calculi explode all trees</LI>
<LI>MeSH descriptor Urolithiasis, this term only</LI>
<LI>(urolithiasis):ti,ab,kw in Clinical Trials</LI>
<LI>(urin* stone*):ti,ab,kw or (urin* calcul*):ti,ab,kw in Clinical Trials</LI>
<LI>(#10 OR #11 OR #12 OR #13)</LI>
<LI>(#9 AND #14)</LI>
</OL>
<P/>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>MEDLINE (OVID)</P>
</TD>
<TD>
<OL>
<LI>Water/</LI>
<LI>Drinking/</LI>
<LI>Fluid Therapy/</LI>
<LI>Body Water/</LI>
<LI>Beverages/</LI>
<LI>Mineral Waters/</LI>
<LI>fluid$.tw.</LI>
<LI>drink$.tw.</LI>
<LI>water.tw.</LI>
<LI>or/1-9</LI>
<LI>exp Urinary Calculi/</LI>
<LI>Urolithiasis/</LI>
<LI>urolithiasis.tw.</LI>
<LI>((calcul$ or stone$) and urin$).tw.</LI>
<LI>or/11-14</LI>
<LI>and/10,15</LI>
</OL>
<P/>
</TD>
</TR>
</TABLE>
<P/>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2011-11-14 11:46:31 +1100" MODIFIED_BY="Narelle S Willis" NO="2">
<TITLE MODIFIED="2011-11-14 11:46:29 +1100" MODIFIED_BY="Narelle S Willis">Risk of bias assessment tool</TITLE>
<APPENDIX_BODY MODIFIED="2011-11-14 11:46:31 +1100" MODIFIED_BY="Narelle S Willis">
<TABLE COLS="2" ROWS="22">
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Potential source of bias</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Assessment criteria</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>
<B>Random sequence generation</B>
</P>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</TD>
<TD>
<P>
<I>Low risk of bias: </I>Random number table; computer random number generator; coin tossing; shuffling cards or envelopes; throwing dice; drawing of lots; minimization (minimization may be implemented without a random element, and this is considered to be equivalent to being random).</P>
</TD>
</TR>
<TR>
<TD>
<P>
<I>High risk of bias: </I>Sequence generated by odd or even date of birth; date (or day) of admission; sequence generated by hospital or clinic record number; allocation by judgement of the clinician; by preference of the participant; based on the results of a laboratory test or a series of tests; by availability of the intervention.</P>
</TD>
</TR>
<TR>
<TD>
<P>
<I>Unclear: </I>Insufficient information about the sequence generation process to permit judgement.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>
<B>Allocation concealment</B>
</P>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</TD>
<TD>
<P>
<I>Low risk of bias: </I>Randomisation method described that would not allow investigator/participant to know or influence intervention group before eligible participant entered in the study (e.g. central allocation, including telephone, web-based, and pharmacy-controlled, randomisation; sequentially numbered drug containers of identical appearance; sequentially numbered, opaque, sealed envelopes).</P>
</TD>
</TR>
<TR>
<TD>
<P>
<I>High risk of bias: </I>Using an open random allocation schedule (e.g. a list of random numbers); assignment envelopes were used without appropriate safeguards (e.g. if envelopes were unsealed or non-opaque or not sequentially numbered); alternation or rotation; date of birth; case record number; any other explicitly unconcealed procedure.</P>
</TD>
</TR>
<TR>
<TD>
<P>
<I>Unclear</I>: Randomisation stated but no information on method used is available.</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="3" VALIGN="TOP">
<P>
<B>Blinding of participants and personnel</B>
</P>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</TD>
<TD>
<P>
<I>Low risk of bias</I>:<I> </I>No blinding or incomplete blinding, but the review authors judge that the outcome is not likely to be influenced by lack of blinding; blinding of participants and key study personnel ensured, and unlikely that the blinding could have been broken.</P>
</TD>
</TR>
<TR>
<TD>
<P>
<I>High risk of bias</I>: No blinding or incomplete blinding, and the outcome is likely to be influenced by lack of blinding; blinding of key study participants and personnel attempted, but likely that the blinding could have been broken, and the outcome is likely to be influenced by lack of blinding.</P>
</TD>
</TR>
<TR>
<TD>
<P>
<I>Unclear</I>: Insufficient information to permit judgement</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>
<B>Blinding of outcome assessment</B>
</P>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors.</P>
</TD>
<TD>
<P>
<I>Low risk of bias: </I>No blinding of outcome assessment, but the review authors judge that the outcome measurement is not likely to be influenced by lack of blinding; blinding of outcome assessment ensured, and unlikely that the blinding could have been broken.</P>
</TD>
</TR>
<TR>
<TD>
<P>
<I>High risk of bias: </I>No blinding of outcome assessment, and the outcome measurement is likely to be influenced by lack of blinding; blinding of outcome assessment, but likely that the blinding could have been broken, and the outcome measurement is likely to be influenced by lack of blinding.</P>
</TD>
</TR>
<TR>
<TD>
<P>
<I>Unclear: </I>Insufficient information to permit judgement</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>
<B>Incomplete outcome data</B>
</P>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data.</P>
</TD>
<TD>
<P>
<I>Low risk of bias: </I>No missing outcome data; reasons for missing outcome data unlikely to be related to true outcome (for survival data, censoring unlikely to be introducing bias); missing outcome data balanced in numbers across intervention groups, with similar reasons for missing data across groups; for dichotomous outcome data, the proportion of missing outcomes compared with observed event risk not enough to have a clinically relevant impact on the intervention effect estimate; for continuous outcome data, plausible effect size (difference in means or standardized difference in means) among missing outcomes not enough to have a clinically relevant impact on observed effect size; missing data have been imputed using appropriate methods.</P>
</TD>
</TR>
<TR>
<TD>
<P>
<I>High risk of bias: </I>Reason for missing outcome data likely to be related to true outcome, with either imbalance in numbers or reasons for missing data across intervention groups; for dichotomous outcome data, the proportion of missing outcomes compared with observed event risk enough to induce clinically relevant bias in intervention effect estimate; for continuous outcome data, plausible effect size (difference in means or standardized difference in means) among missing outcomes enough to induce clinically relevant bias in observed effect size; &#8216;as-treated&#8217; analysis done with substantial departure of the intervention received from that assigned at randomisation; potentially inappropriate application of simple imputation.</P>
</TD>
</TR>
<TR>
<TD>
<P>
<I>Unclear: </I>Insufficient information to permit judgement</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>
<B>Selective reporting</B>
</P>
<P>Reporting bias due to selective outcome reporting</P>
</TD>
<TD>
<P>
<I>Low risk of bias: </I>The study protocol is available and all of the study&#8217;s pre-specified (primary and secondary) outcomes that are of interest in the review have been reported in the pre-specified way; the study protocol is not available but it is clear that the published reports include all expected outcomes, including those that were pre-specified (convincing text of this nature may be uncommon).</P>
</TD>
</TR>
<TR>
<TD>
<P>
<I>High risk of bias: </I>Not all of the study&#8217;s pre-specified primary outcomes have been reported; one or more primary outcomes is reported using measurements, analysis methods or subsets of the data (e.g. subscales) that were not pre-specified; one or more reported primary outcomes were not pre-specified (unless clear justification for their reporting is provided, such as an unexpected adverse effect); one or more outcomes of interest in the review are reported incompletely so that they cannot be entered in a meta-analysis; the study report fails to include results for a key outcome that would be expected to have been reported for such a study.</P>
</TD>
</TR>
<TR>
<TD>
<P>
<I>Unclear: </I>Insufficient information to permit judgement</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>
<B>Other bias</B>
</P>
<P>Bias due to problems not covered elsewhere in the table</P>
</TD>
<TD>
<P>
<I>Low risk of bias: </I>The study appears to be free of other sources of bias.</P>
</TD>
</TR>
<TR>
<TD>
<P>
<I>High risk of bias:</I> Had a potential source of bias related to the specific study design used; stopped early due to some data-dependent process (including a formal-stopping rule); had extreme baseline imbalance; has been claimed to have been fraudulent; had some other problem.</P>
</TD>
</TR>
<TR>
<TD>
<P>
<I>Unclear: </I>Insufficient information to assess whether an important risk of bias exists; insufficient rationale or evidence that an identified problem will introduce bias.</P>
</TD>
</TR>
</TABLE>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS>
<EXTENSION ID="FLOW_1" NAME="FIGURE" REVMAN_VERSION="5.1.0" TYPE="FLOWCHART">
<ALIAS ALIAS_ID="1">
<FLOWCHARTBOX TEXT="&lt;p&gt;Included studies: 1&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;Full-text review: 13&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;Number of records screened: 3521&lt;/p&gt;" WIDTH="220">
<FLOWCHARTBOX TEXT="&lt;p&gt;MEDLINE: 1636&lt;/p&gt;" WIDTH="120"/>
<FLOWCHARTBOX TEXT="&lt;p&gt;CENTRAL/Renal register&lt;/p&gt;&lt;ul&gt;&lt;li&gt;Original review: 191&lt;/li&gt;&lt;li&gt;2012 update: 10&lt;/li&gt;&lt;/ul&gt;" WIDTH="200"/>
<FLOWCHARTBOX TEXT="&lt;p&gt;EMBASE: 1684&lt;/p&gt;" WIDTH="120"/>
<OUT TEXT="&lt;p&gt;Excluded records: 3508&lt;/p&gt;" WIDTH="180"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;Excluded reports: 11&lt;/p&gt;&lt;ul&gt;&lt;li&gt;Original review: 2&lt;/li&gt;&lt;li&gt;2012 update: 9&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;Not RCT, wrong comparator or intervention&lt;/p&gt;" WIDTH="280"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;Ongoing studies: 1&lt;/p&gt;" WIDTH="150"/>
</FLOWCHARTBOX>
</ALIAS>
</EXTENSION>
</EXTENSIONS>
</COCHRANE_REVIEW>